Rolly Simpson, BW Fund, Former Librarian BW USA

Interviewee joined the company in 1973 in the library which said within the research function. He moved to the BW Fund after the merger with Glaxo.

Topics discussed include:

* general view of BW in 1970s

* Research Triangle Park building, move to North Carolina and change in company's image

* information management within BW inc: advances in information provision; Product Bibliography database; management of databases; legal requirements for information

* Therapeutic Advisory Panels, the Pharmaco-Epidemiology Panel

* creation of the quality of life ratings, and Quality of Life Journal

* George Hitchings

* research in BW: focus, procedure

* Purinethol (leukaemia drug), Zyloprim, Imuran, Daraprim

* relationship with UK company

* Pedro Cuatrecasas

* relationship between research and the rest of the company, inc the Wellcome Lectures, given by scientists to staff

* merger and flotation

* Bill Sullivan, management style, McKinsey report, departure from company

* David Barry

* changes in research department

* Ted Haigler

* Phil Tracy

* Peter Howsam

* Glaxo in 1980s, marketing strategy, Zantac

* Retrovir, pricing, public reaction, BW reputation

* BW Fund * Illico Clamatos [?]

10 May 2001

4 audio tapes and transcript Tape 20, 21

This item needs to be accessed onsite using specialist equipment. Email collections@wellcomecollection.org to request an appointment.